These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
262 related items for PubMed ID: 12237257
1. Pharmacological characterization of the novel nociceptin/orphanin FQ receptor ligand, ZP120: in vitro and in vivo studies in mice. Rizzi A, Rizzi D, Marzola G, Regoli D, Larsen BD, Petersen JS, Calo' G. Br J Pharmacol; 2002 Oct; 137(3):369-74. PubMed ID: 12237257 [Abstract] [Full Text] [Related]
8. Comparative biochemical and pharmacological characterization of a novel, NOP receptor selective hexapeptide, Ac-RYYRIR-ol. Bojnik E, Babos F, Fischetti C, Magyar A, Camarda V, Borsodi A, Bajusz S, Calo' G, Benyhe S. Brain Res Bull; 2010 Mar 16; 81(4-5):477-83. PubMed ID: 19800951 [Abstract] [Full Text] [Related]
13. [Arg(14),Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies. Rizzi D, Rizzi A, Bigoni R, Camarda V, Marzola G, Guerrini R, De Risi C, Regoli D, Calo' G. J Pharmacol Exp Ther; 2002 Jan 16; 300(1):57-63. PubMed ID: 11752097 [Abstract] [Full Text] [Related]
15. Pharmacological characterization of nociceptin/orphanin FQ receptors, a novel opioid receptor family, in the midbrain periaqueductal gray. Chiou LC, Fan SH, Chuang KC, Liao YY, Lee SZ. Ann N Y Acad Sci; 2004 Oct 16; 1025():398-403. PubMed ID: 15542742 [Abstract] [Full Text] [Related]
16. The effects of [Arg14, Lys15] nociceptin/orphanin FQ, a highly potent agonist of the NOP receptor, on in vitro and in vivo gastrointestinal functions. Broccardo M, Linari G, Guerrini R, Agostini S, Petrella C, Improta G. Peptides; 2005 Sep 16; 26(9):1590-7. PubMed ID: 16112397 [Abstract] [Full Text] [Related]